HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

BIOSTAR PHARM-B

3.100

-0.050-1.59%

Volume:6.40K

Turnover:19.77K

Market Cap:1.13B

PE:-6.94

High:3.100

Open:3.060

Low:3.060

Close:3.150

52wk High:39.500

52wk Low:2.400

Shares:364.59M

HK Float Shares:216.72M

Volume Ratio:0.13

T/O Rate:0.00%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.447

ROE:-18.99%

ROA:-12.47%

PB:1.38

PE(LYR):-6.94

PS:19.28

Loading ...

Overview Company News Filings

Beijing Biostar Pharmaceuticals (02563) Publishes Monthly Return for October 2025

Bulletin Express

HK Stock Movement | BIOSTAR PHARM-B (02563) Plunges Over 37% as Major Share Unlock Hits Post One-Year Listing

BIOSTAR PHARM-B (02563) Shareholders Deposit Shares with Huatai Hong Kong Worth HK$125 Million

FDA Grants Orphan Drug Designation to Biostar Pharma’s Utidelone for Treatment of Pancreatic Cancer

Biostar Pharma Initiates Phase II/III Clinical Trials for Utidelone Capsule Targeting Gastric and Ovarian Cancers

Biostar Pharma Successively Achieved First Patient Dosing for Two Phase Ii/Iii Multiregional Clinical Trials of Utidelone Capsule (Utd2)

THOMSON REUTERS

BIOSTAR PHARM-B (02563) Reports Interim Results with Net Loss of RMB 54.04 Million, Narrowing 23.41% Year-on-Year

HK Movers｜HK Innovative Drug Concept Stocks Rose. Biostar Up 15%; Akeso Up 11%; SKB Bio And Innovent Bio Up More Than 7%

Tiger Newspress

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/02563/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02563","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02563\",,,,,undefined,":{"symbol":"02563","market":"HK","secType":"STK","nameCN":"BIOSTAR PHARM-B","latestPrice":3.1,"timestamp":1763101935719,"preClose":3.15,"halted":0,"volume":6400,"delay":0,"floatShares":216720857,"shares":364588000,"eps":-0.44659987102288173,"marketStatus":"Trading","change":-0.05,"latestTime":"11-14 14:36:37","open":3.06,"high":3.1,"low":3.06,"amount":19770,"amplitude":0.012698,"askPrice":3.17,"askSize":1400,"bidPrice":3.1,"bidSize":6800,"shortable":0,"etf":0,"ttmEps":-0.3872740215220854,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1763107800000},"marketStatusCode":2,"adr":0,"listingDate":1730304000000,"exchange":"SEHK","adjPreClose":3.15,"openAndCloseTimeList":[[1763083800000,1763092800000],[1763096400000,1763107200000]],"volumeRatio":0.133854,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02563\",,,,,undefined,":{"symbol":"02563","floatShares":216720857,"roa":"-12.47%","roe":"-18.99%","lyrEps":-0.4466,"volumeRatio":0.133854,"shares":364588000,"dividePrice":0,"high":3.1,"amplitude":0.012698,"preClose":3.15,"low":3.06,"week52Low":2.4,"pbRate":"1.38","psRate":"19.28","week52High":39.5,"institutionHeld":0,"latestPrice":3.1,"committee":0.658537,"eps":-0.44659987102288173,"divideRate":0,"volume":6400,"delay":0,"ttmEps":-0.3872740215220854,"open":3.06,"prevYearClose":19.7,"prevWeekClose":3.1,"prevMonthClose":3.35,"prevQuarterClose":8.93,"fiveDayClose":3.1,"twentyDayClose":6.63,"sixtyDayClose":8.76},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02563\",params:#limit:5,,,undefined,":[{"date":"2025-08-28","symbol":"02563","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756344600000,"name":null,"time":"","dateTimestamp":1756310400000,"actualEps":null},{"date":"2025-06-30","symbol":"02563","type":"earning","reportTimeType":"pre","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1751247000000,"name":null,"time":"Pre-Market","dateTimestamp":1751212800000,"actualEps":null},{"date":"2025-03-31","symbol":"02563","type":"earning","reportTimeType":"pre","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743384600000,"name":null,"time":"Pre-Market","dateTimestamp":1743350400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02563\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02563\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":1,"buy":0,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":1,"analysts":1,"updateTime":1734364800000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02563\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02563","date":"2025-11-13","current":-7.900213,"percent":0.992188,"low":-63.892303,"twenty":-29.486496,"median":-12.467667,"eighty":-7.916664,"high":-4.834251,"avg":-20.377297,"sd":15.995679,"marketCap":682670699},"quantilePoints":[{"date":"2024-11-01","current":-45.939002,"twenty":-42.207558,"median":-36.610392,"eighty":-34.727382,"marketCap":9515746800},{"date":"2024-11-08","current":-50.657086,"twenty":-48.301262,"median":-46.125418,"eighty":-40.341836,"marketCap":10445446200},{"date":"2024-11-15","current":-51.735366,"twenty":-51.259815,"median":-49.659484,"eighty":-46.008352,"marketCap":10554822600},{"date":"2024-11-22","current":-51.670488,"twenty":-51.75324,"median":-50.936861,"eighty":-46.12281,"marketCap":10536593200},{"date":"2024-11-29","current":-50.005514,"twenty":-51.751568,"median":-51.216637,"eighty":-46.188646,"marketCap":10190234600},{"date":"2024-12-06","current":-53.261904,"twenty":-52.309165,"median":-51.551619,"eighty":-47.62215,"marketCap":10828263600},{"date":"2024-12-13","current":-56.152393,"twenty":-53.128108,"median":-51.673125,"eighty":-49.762114,"marketCap":11393375000},{"date":"2024-12-20","current":-57.66573,"twenty":-54.870186,"median":-51.763763,"eighty":-49.951841,"marketCap":11648586600},{"date":"2024-12-27","current":-56.987991,"twenty":-56.152393,"median":-51.943964,"eighty":-50.005514,"marketCap":11502751400},{"date":"2025-01-03","current":-29.160861,"twenty":-55.458441,"median":-51.76237,"eighty":-46.238834,"marketCap":5891742080},{"date":"2025-01-10","current":-29.88764,"twenty":-55.141356,"median":-51.671807,"eighty":-37.690323,"marketCap":6015702000},{"date":"2025-01-17","current":-26.098924,"twenty":-54.634915,"median":-51.456455,"eighty":-29.807432,"marketCap":5257358960},{"date":"2025-01-24","current":-31.83595,"twenty":-54.024096,"median":-50.936861,"eighty":-29.486496,"marketCap":6453207600},{"date":"2025-01-28","current":-29.272366,"twenty":-53.898416,"median":-50.551705,"eighty":-29.486183,"marketCap":5964659680},{"date":"2025-02-07","current":-27.891403,"twenty":-53.763486,"median":-49.916059,"eighty":-28.779902,"marketCap":5651114000},{"date":"2025-02-14","current":-27.724819,"twenty":-53.195006,"median":-46.201193,"eighty":-28.045447,"marketCap":5614655200},{"date":"2025-02-21","current":-31.716408,"twenty":-52.922578,"median":-45.939002,"eighty":-28.200859,"marketCap":6445915840},{"date":"2025-02-28","current":-28.761543,"twenty":-52.84984,"median":-36.099768,"eighty":-28.259952,"marketCap":5826116240},{"date":"2025-03-07","current":-27.678496,"twenty":-52.618251,"median":-32.29046,"eighty":-28.259952,"marketCap":5629238720},{"date":"2025-03-14","current":-19.855324,"twenty":-52.427717,"median":-31.776179,"eighty":-27.893524,"marketCap":4039635040},{"date":"2025-03-21","current":-15.488933,"twenty":-51.9516,"median":-30.932826,"eighty":-27.594014,"marketCap":3150040320},{"date":"2025-03-28","current":-9.592432,"twenty":-51.908202,"median":-29.673915,"eighty":-27.348197,"marketCap":1946899920},{"date":"2025-04-03","current":-7.937518,"twenty":-51.765156,"median":-29.469494,"eighty":-26.098924,"marketCap":1607833080},{"date":"2025-04-11","current":-7.990601,"twenty":-51.76237,"median":-29.160861,"eighty":-21.966366,"marketCap":1607833080},{"date":"2025-04-17","current":-7.971477,"twenty":-51.740767,"median":-28.859539,"eighty":-19.722121,"marketCap":1607833080},{"date":"2025-04-25","current":-7.964599,"twenty":-51.698021,"median":-28.761543,"eighty":-16.327761,"marketCap":1607833080},{"date":"2025-05-02","current":-7.947706,"twenty":-51.67207,"median":-28.684662,"eighty":-12.879685,"marketCap":1607833080},{"date":"2025-05-09","current":-7.892301,"twenty":-51.665747,"median":-28.653449,"eighty":-9.667878,"marketCap":1607833080},{"date":"2025-05-16","current":-7.828344,"twenty":-51.608717,"median":-28.420136,"eighty":-7.99153,"marketCap":1607833080},{"date":"2025-05-23","current":-7.804998,"twenty":-51.422884,"median":-28.295023,"eighty":-7.977687,"marketCap":1607833080},{"date":"2025-05-30","current":-7.770834,"twenty":-51.274208,"median":-28.099009,"eighty":-7.965975,"marketCap":1607833080},{"date":"2025-06-06","current":-7.751059,"twenty":-51.104727,"median":-27.891403,"eighty":-7.948076,"marketCap":1607833080},{"date":"2025-06-13","current":-7.747995,"twenty":-50.614934,"median":-27.692071,"eighty":-7.919515,"marketCap":1607833080},{"date":"2025-06-20","current":-7.763212,"twenty":-50.358163,"median":-27.513301,"eighty":-7.892411,"marketCap":1607833080},{"date":"2025-06-27","current":-7.741532,"twenty":-49.987623,"median":-27.370929,"eighty":-7.828813,"marketCap":1607833080},{"date":"2025-07-04","current":-11.83634,"twenty":-49.916059,"median":-26.913642,"eighty":-7.828344,"marketCap":1863799370},{"date":"2025-07-11","current":-10.622116,"twenty":-49.659484,"median":-25.451597,"eighty":-7.830688,"marketCap":1670917807},{"date":"2025-07-18","current":-10.713174,"twenty":-46.263928,"median":-22.166181,"eighty":-7.835505,"marketCap":1683921058},{"date":"2025-07-25","current":-11.004065,"twenty":-46.138458,"median":-20.500443,"eighty":-7.892301,"marketCap":1735934064},{"date":"2025-08-01","current":-10.726899,"twenty":-46.112378,"median":-18.6504,"eighty":-7.892301,"marketCap":1681753850},{"date":"2025-08-08","current":-11.168953,"twenty":-45.939002,"median":-15.488933,"eighty":-7.892849,"marketCap":1755438941},{"date":"2025-08-15","current":-11.738095,"twenty":-37.960306,"median":-13.174334,"eighty":-7.893093,"marketCap":1842127284},{"date":"2025-08-22","current":-12.467667,"twenty":-36.610392,"median":-12.190608,"eighty":-7.916058,"marketCap":1950487713},{"date":"2025-08-29","current":-11.994815,"twenty":-35.589144,"median":-12.330873,"eighty":-7.919087,"marketCap":1885471455},{"date":"2025-09-05","current":-13.970683,"twenty":-33.472042,"median":-12.571701,"eighty":-7.921226,"marketCap":1941818878},{"date":"2025-09-12","current":-13.494215,"twenty":-32.29046,"median":-13.141338,"eighty":-7.937518,"marketCap":1878969830},{"date":"2025-09-19","current":-13.239018,"twenty":-32.065299,"median":-13.33247,"eighty":-7.944288,"marketCap":1842127284},{"date":"2025-09-26","current":-13.445231,"twenty":-31.83595,"median":-13.275502,"eighty":-7.947706,"marketCap":1865966578},{"date":"2025-10-03","current":-13.148382,"twenty":-31.740316,"median":-13.293416,"eighty":-7.949184,"marketCap":1829124033},{"date":"2025-10-10","current":-11.950662,"twenty":-31.35646,"median":-13.24589,"eighty":-7.956191,"marketCap":1660081764},{"date":"2025-10-17","current":-9.930211,"twenty":-31.006293,"median":-13.148382,"eighty":-7.963006,"marketCap":1378344650},{"date":"2025-10-24","current":-7.991227,"twenty":-30.305714,"median":-13.037443,"eighty":-7.964599,"marketCap":1109610787},{"date":"2025-10-31","current":-5.220848,"twenty":-29.877076,"median":-12.972224,"eighty":-7.953979,"marketCap":726014870},{"date":"2025-11-07","current":-4.834251,"twenty":-29.711378,"median":-12.571701,"eighty":-7.940226,"marketCap":671834656},{"date":"2025-11-13","current":-4.898343,"twenty":-29.486496,"median":-12.467667,"eighty":-7.916664,"marketCap":682670699}],"updateTime":1763091282363},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02563\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1172737033","title":"Beijing Biostar Pharmaceuticals (02563) Publishes Monthly Return for October 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1172737033","media":"Bulletin Express","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172737033?lang=en_us&edition=fundamental","pubTime":"2025-11-03 19:01","pubTimestamp":1762167674,"startTime":"0","endTime":"0","summary":"Beijing Biostar Pharmaceuticals Co., Ltd. (02563) submitted its Monthly Return on Movements in Securities for the period ended 31 October 2025. The company reported that its total registered share...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02563"],"gpt_icon":0},{"id":"1109626394","title":"HK Stock Movement | BIOSTAR PHARM-B (02563) Plunges Over 37% as Major Share Unlock Hits Post One-Year Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=1109626394","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109626394?lang=en_us&edition=fundamental","pubTime":"2025-10-31 11:00","pubTimestamp":1761879635,"startTime":"0","endTime":"0","summary":"BIOSTAR PHARM-B (02563) saw its shares plummet more than 37% intraday. At press time, the stock was down 29.98% to HK$3.55, with a turnover of HK$5.82 million. The sharp decline followed the...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1574","09939","BK1515","159938","02563"],"gpt_icon":0},{"id":"1176635985","title":"BIOSTAR PHARM-B (02563) Shareholders Deposit Shares with Huatai Hong Kong Worth HK$125 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1176635985","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176635985?lang=en_us&edition=fundamental","pubTime":"2025-10-15 08:30","pubTimestamp":1760488225,"startTime":"0","endTime":"0","summary":"According to the latest data from the Hong Kong Stock Exchange, on October 14th, shareholders of BIOSTAR PHARM-B (02563) deposited shares with Huatai Hong Kong, with a custody market value of HK$125...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","BK1574","BK1161","159938","02563","BK1515"],"gpt_icon":0},{"id":"2570522013","title":"FDA Grants Orphan Drug Designation to Biostar Pharma’s Utidelone for Treatment of Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2570522013","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570522013?lang=en_us&edition=fundamental","pubTime":"2025-09-25 21:38","pubTimestamp":1758807539,"startTime":"0","endTime":"0","summary":"**Biostar Pharma's Utidelone Receives FDA Orphan Drug Designation for Pancreatic Cancer** SAN FRANCISCO, Sept. 25, 2025 - Biostar Pharma, Inc., a wholly-owned subsidiary of Beijing Biostar Biopharmaceutical Co., Ltd., has announced that its core pipeline product, Utidelone, has been granted Orphan Drug Designation  by the U.S. Food and Drug Administration  for the treatment of pancreatic cancer. This marks the third ODD for Utidelone, following previous designations for breast cancer brain metastases and gastric cancer. The FDA's decision is based on promising preclinical and early clinical results, including a Phase II study showing an objective response rate of 27.27% and a disease control rate of 72.72% in advanced, unresectable pancreatic cancer. No other organizations were named as recipients of this regulatory designation. Pancreatic cancer remains one of the most challenging malignancies to treat, with a five-year survival rate of just 10%. Utidelone's new designation highlights","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250925:nNDL5Txcxb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02563"],"gpt_icon":0},{"id":"2567119284","title":"Biostar Pharma Initiates Phase II/III Clinical Trials for Utidelone Capsule Targeting Gastric and Ovarian Cancers","url":"https://stock-news.laohu8.com/highlight/detail?id=2567119284","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567119284?lang=en_us&edition=fundamental","pubTime":"2025-09-15 20:01","pubTimestamp":1757937696,"startTime":"0","endTime":"0","summary":"Biostar Pharma, the US subsidiary of Beijing Biostar Pharmaceuticals Co., Ltd., has announced the initiation of two phase II/III multiregional clinical trials for the Utidelone Capsule . The trials focus on the first-line treatment for locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma and the treatment for platinum-resistant advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer. The first patients were dosed on September 11 and September 12, 2025, respectively. Utidelone is noted for its higher oral bioavailability and lower risk of cross-resistance compared to taxanes, which enhances its convenience and potential in combination therapies. The company has not yet presented results from these ongoing trials.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250915:nNDL7sPw5y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02563"],"gpt_icon":0},{"id":"2567119279","title":"Biostar Pharma Successively Achieved First Patient Dosing for Two Phase Ii/Iii Multiregional Clinical Trials of Utidelone Capsule (Utd2)","url":"https://stock-news.laohu8.com/highlight/detail?id=2567119279","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567119279?lang=en_us&edition=fundamental","pubTime":"2025-09-15 20:00","pubTimestamp":1757937612,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250915:nTUA92THRR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02563","BK1161"],"gpt_icon":0},{"id":"1178879979","title":"BIOSTAR PHARM-B (02563) Reports Interim Results with Net Loss of RMB 54.04 Million, Narrowing 23.41% Year-on-Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1178879979","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178879979?lang=en_us&edition=fundamental","pubTime":"2025-08-28 19:17","pubTimestamp":1756379845,"startTime":"0","endTime":"0","summary":"BIOSTAR PHARM-B (02563) announced its interim results for the six months ended June 30, 2025. The company reported revenue of RMB 14.787 million, representing a decrease of 55.36% compared to the...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02563","BK1515","BK1161","159938","09939","BK1574"],"gpt_icon":0},{"id":"1109523465","title":"HK Movers｜HK Innovative Drug Concept Stocks Rose. Biostar Up 15%; Akeso Up 11%; SKB Bio And Innovent Bio Up More Than 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1109523465","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109523465?lang=en_us&edition=fundamental","pubTime":"2025-07-03 11:00","pubTimestamp":1751511647,"startTime":"0","endTime":"0","summary":"HK Innovative Drug Concept Stocks Rose. Biostar up 15%; Akeso up 11%; SKB Bio and Innovent Bio up more than 7%; Zai Lab up 5%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"8f9423fb69201ea469acc4a9341fc19e","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672","01801","09966","02268","03759","06990","09995","09606","06978","06606","09926","02359","03347","02269","02563","02137","09688"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":8,"code":"91000000","status":"200"}]}}